The IBD SmartSelect Composite Rating for Enova International rose from 94 to 97 Monday.
The revised score means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. History shows the top market performers tend to have a 95 or higher score as they launch their major climbs.
Enova International is not currently near a proper buy zone. Look for the stock to form and break out of a new chart pattern.
Lean How — And When — To Sell Stocks
The stock has a 93 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth is outpacing 93% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q4, the company reported 43% EPS growth. Revenue was flat, matching the prior quarter's 25%.
Enova International earns the No. 2 rank among its peers in the Finance-Consumer Loans industry group. Atlanticus Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
